Showing results (341-350 of 378) with videos related to
Sort By:
Pageof 38
British Journal of Cancer|July 17, 2008
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancerP de Graeff, A P G Crijns, K A Ten Hoor, et al.BMC Medicine|June 24, 2017
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancerTushar Tomar, Nicolette G Alkema, Leroy Schreuder, et al.Neurology|June 21, 2008
Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer diseaseN Brouwers, K Sleegers, S Engelborghs, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft modelEvelien W Duiker, Elisabeth G E de Vries, Devalingam Mahalingam, et al.Neurology|August 26, 2009
Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159HisJ van der Zee, D Pirici, T Van Langenhove, et al.British Journal of Cancer|July 18, 2014
DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive womenA Boers, R P Bosgraaf, R W van Leeuwen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancerNathalie Reesink-Peters, Jacobus van der Velden, Klaske A Ten Hoor, et al.Plos One|October 3, 2013
Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progressionMariana Brait, Leonel Maldonado, Maartje G Noordhuis, et al.Trials|January 10, 2020
Early intervention for children at risk of visual processing dysfunctions from 1 year of age: a randomized controlled trial protocolMarlou J G Kooiker, Yoni van der Linden, Jenneke van Dijk, et al.International Journal of Cancer|August 19, 2005
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasiaMariëtte I E van Poelgeest, Esther R Nijhuis, Kitty M C Kwappenberg, et al.Pageof 38